HENRY SCHEIN INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HENRY SCHEIN INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 29, 2018 | $3.38B | Feb 20, 2019 |
| FY2018 | Sep 29, 2018 | $3.28B | Feb 20, 2019 |
| FY2018 | Jun 30, 2018 | $3.33B | Feb 20, 2019 |
| FY2018 | Mar 31, 2018 | $3.22B | Feb 20, 2019 |
| FY2018 | Dec 30, 2017 | $3.32B | Feb 20, 2019 |
| FY2018 | Sep 30, 2017 | $3.16B | Feb 20, 2019 |
| FY2018 | Jul 1, 2017 | $3.06B | Feb 20, 2019 |
| FY2018 | Apr 1, 2017 | $2.92B | Feb 20, 2019 |
| FY2018 | Dec 31, 2016 | $11.57B | Feb 20, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $13.18B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $12.67B | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $12.34B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $12.65B | Feb 25, 2025 |
| FY2023 | Dec 25, 2021 | $12.40B | Feb 28, 2024 |
| FY2020 | Dec 26, 2020 | $3.17B | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | $2.84B | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | $1.68B | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | $2.43B | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | $2.67B | Feb 17, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 30, 2017 | $3.32B | Feb 21, 2018 |
| FY2017 | Sep 30, 2017 | $3.16B | Feb 21, 2018 |
| FY2017 | Jul 1, 2017 | $3.06B | Feb 21, 2018 |
| FY2017 | Apr 1, 2017 | $2.92B | Feb 21, 2018 |
| FY2017 | Dec 31, 2016 | $3.12B | Feb 21, 2018 |
| FY2017 | Sep 24, 2016 | $2.87B | Feb 21, 2018 |
| FY2017 | Jun 25, 2016 | $2.87B | Feb 21, 2018 |
| FY2017 | Mar 26, 2016 | $2.71B | Feb 21, 2018 |
| FY2016 | Dec 26, 2015 | $2.85B | Feb 21, 2017 |
| FY2016 | Sep 26, 2015 | $2.69B | Feb 21, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $4.11B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $4.02B | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $3.86B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $3.83B | Feb 25, 2025 |
| FY2023 | Dec 25, 2021 | $3.67B | Feb 28, 2024 |
| FY2020 | Dec 26, 2020 | $859.71M | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | $754.30M | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | $454.29M | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | $746.04M | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | $810.60M | Feb 17, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $398.00M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $390.00M | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $416.00M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $538.00M | Feb 25, 2025 |
| FY2023 | Dec 25, 2021 | $631.00M | Feb 28, 2024 |
| FY2022 | Dec 26, 2020 | $404.00M | Feb 21, 2023 |
| FY2019 | Dec 28, 2019 | $330.61M | Feb 20, 2020 |
| FY2019 | Sep 28, 2019 | $134.92M | Feb 20, 2020 |
| FY2019 | Jun 29, 2019 | $116.75M | Feb 20, 2020 |
| FY2019 | Mar 30, 2019 | $118.41M | Feb 20, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $653.00M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $621.00M | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $615.00M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $747.00M | Feb 25, 2025 |
| FY2023 | Dec 25, 2021 | $852.00M | Feb 28, 2024 |
| FY2020 | Dec 26, 2020 | $181.20M | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | $187.67M | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | ($7.43M) | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | $173.87M | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | $196.33M | Feb 17, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $3.08B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $3.03B | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $2.96B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $2.77B | Feb 25, 2025 |
| FY2023 | Dec 25, 2021 | $2.63B | Feb 28, 2024 |
| FY2022 | Dec 26, 2020 | $2.09B | Feb 21, 2023 |
| FY2021 | Dec 28, 2019 | $2.36B | Feb 15, 2022 |
| FY2020 | Dec 29, 2018 | $2.22B | Feb 17, 2021 |
| FY2019 | Dec 30, 2017 | $2.07B | Feb 20, 2020 |
| FY2017 | Dec 31, 2016 | $2.41B | Feb 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $712.00M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $848.00M | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $500.00M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $602.00M | Feb 25, 2025 |
| FY2023 | Dec 25, 2021 | $710.00M | Feb 28, 2024 |
| FY2022 | Dec 26, 2020 | $599.00M | Feb 21, 2023 |
| FY2021 | Dec 28, 2019 | $654.09M | Feb 15, 2022 |
| FY2020 | Dec 29, 2018 | $684.71M | Feb 17, 2021 |
| FY2019 | Dec 30, 2017 | $545.52M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $642.58M | Feb 20, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $11.22B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $10.22B | Feb 24, 2026 |
| FY2024 | Dec 30, 2023 | $10.57B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $8.61B | Feb 28, 2024 |
| FY2023 | Dec 25, 2021 | $8.48B | Feb 28, 2024 |
| FY2022 | Dec 26, 2020 | $7.77B | Feb 21, 2023 |
| FY2021 | Dec 28, 2019 | $7.15B | Feb 15, 2022 |
| FY2020 | Dec 29, 2018 | $8.50B | Feb 17, 2021 |
| FY2019 | Dec 30, 2017 | $7.86B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $6.81B | Feb 20, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $6.42B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $5.38B | Feb 24, 2026 |
| FY2024 | Dec 30, 2023 | $5.42B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $3.94B | Feb 28, 2024 |
| FY2022 | Dec 25, 2021 | $3.81B | Feb 21, 2023 |
| FY2021 | Dec 26, 2020 | $3.46B | Feb 15, 2022 |
| FY2020 | Dec 28, 2019 | $3.23B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $4.65B | Feb 20, 2020 |
| FY2018 | Dec 30, 2017 | $4.21B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $3.35B | Feb 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $3.25B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $3.39B | Feb 24, 2026 |
| FY2024 | Dec 30, 2023 | $3.66B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $3.45B | Feb 28, 2024 |
| FY2022 | Dec 25, 2021 | $3.43B | Feb 21, 2023 |
| FY2021 | Dec 26, 2020 | $3.35B | Feb 15, 2022 |
| FY2020 | Dec 28, 2019 | $3.00B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $2.96B | Feb 20, 2020 |
| FY2018 | Dec 30, 2017 | $2.81B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $2.79B | Feb 21, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $4.21B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $3.89B | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $3.88B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $2.89B | Feb 25, 2025 |
| FY2023 | Dec 25, 2021 | $2.85B | Feb 28, 2024 |
| FY2022 | Dec 26, 2020 | $2.50B | Feb 21, 2023 |
| FY2021 | Dec 28, 2019 | $2.46B | Feb 15, 2022 |
| FY2020 | Dec 29, 2018 | $2.08B | Feb 17, 2021 |
| FY2019 | Dec 30, 2017 | $1.55B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $2.02B | Feb 20, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $3.29B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $3.77B | Feb 24, 2026 |
| FY2024 | Dec 30, 2023 | $3.86B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $3.68B | Feb 28, 2024 |
| FY2022 | Dec 25, 2021 | $3.60B | Feb 21, 2023 |
| FY2021 | Dec 26, 2020 | $3.45B | Feb 15, 2022 |
| FY2020 | Dec 28, 2019 | $3.12B | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | $3.21B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $2.94B | Feb 20, 2019 |
| FY2018 | Dec 30, 2017 | $2.94B | Feb 20, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 29, 2018 | $80.21M | Feb 20, 2019 |
| FY2018 | Dec 30, 2017 | $174.66M | Feb 20, 2019 |
| FY2018 | Dec 31, 2016 | $62.38M | Feb 20, 2019 |
| FY2018 | Dec 26, 2015 | $72.09M | Feb 20, 2019 |
| FY2017 | Dec 27, 2014 | $89.47M | Feb 21, 2018 |
| FY2016 | Dec 28, 2013 | $188.62M | Feb 21, 2017 |
| FY2015 | Dec 29, 2012 | $122.08M | Feb 10, 2016 |
| FY2014 | Dec 31, 2011 | $147.28M | Feb 11, 2015 |
| FY2013 | Dec 25, 2010 | $150.35M | Feb 11, 2014 |
| FY2012 | Dec 26, 2009 | $471.15M | Feb 13, 2013 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $1.05B | Feb 21, 2023 |
| FY2022 | Dec 25, 2021 | $822.00M | Feb 21, 2023 |
| FY2011 | Dec 31, 2011 | $386.34M | Feb 15, 2012 |
| FY2010 | Dec 25, 2010 | $399.80M | Feb 22, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 3 | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | 3 | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | 3 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 25, 2025 |
| FY2023 | Dec 25, 2021 | 4 | Feb 28, 2024 |
| FY2020 | Dec 26, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | 2 | Feb 17, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 3 | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | 3 | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | 3 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 25, 2025 |
| FY2023 | Dec 25, 2021 | 4 | Feb 28, 2024 |
| FY2020 | Dec 26, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Sep 26, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Jun 27, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Mar 28, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Dec 28, 2019 | 2 | Feb 17, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 115.77M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | 124.16M | Feb 24, 2026 |
| FY2024 | Dec 30, 2023 | 129.25M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 131.79M | Feb 28, 2024 |
| FY2022 | Dec 25, 2021 | 137.15M | Feb 21, 2023 |
| FY2021 | Dec 26, 2020 | 142.46M | Feb 15, 2022 |
| FY2020 | Dec 28, 2019 | 143.35M | Feb 17, 2021 |
| FY2019 | Dec 29, 2018 | 151.40M | Feb 20, 2020 |
| FY2018 | Dec 30, 2017 | 153.69M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | 158.81M | Feb 21, 2018 |